Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as C$0.10 and last traded at C$0.09, with a volume of 1155773 shares. The stock had previously closed at C$0.09.
MediPharm Labs Stock Performance
The company has a current ratio of 3.28, a quick ratio of 3.10 and a debt-to-equity ratio of 4.93. The business’s 50 day moving average is C$0.07 and its 200 day moving average is C$0.07. The stock has a market capitalization of C$32.10 million, a PE ratio of -1.80 and a beta of 1.04.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Conference Calls and Individual Investors
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What Are the FAANG Stocks and Are They Good Investments?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
